Manila Times Business
Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists
Built on a new AI-native architecture, Concentriq delivers clinically and scientifically grounded intelligence to decisions throughout drug discovery, development, and case review PHILADELPHIA, June 17, 2026 (GLOBE NEWSWIRE) -- Proscia® today introduced the Fifth Generation of its Concentriq®1 platform, helping pathologists focus on high-judgment decisions and enabling scientists to quickly move from early signals to evidence-based program decisions. Proscia is trusted by diagnostic laboratories
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Hontiveros thanks #'WinRi' supporters
3h ago
Share buyback program completed
3h ago
Applied Biologics Announces Completion of Planned Enrollment Activities in the CAMPX Randomized Controlled Trial Evaluating XWRAP®
3h ago
ELLIPAL and N.exchange Announce Partnership to Deliver Self-Custodial, Cross-Chain Crypto Swaps
3h ago